Morgan Stanley
Thoughts on the Market
Short, thoughtful and regular takes on recent events in the markets from a variety of perspectives and voices within Morgan Stanley.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Andrew Sheets: Why Rates Will Rise Next Year, and Why the Fed Will Let Them 10.12.2020 2:39
Many are skeptical of substantial rise in long term interest rates in the coming year, but we think market pressures will push them up more than the consensus and that the Fed will not get in the way. Chief Cross-Asset Strategist Andrew Sheets explains.
Michael Zezas: Can Congress Break the Stimulus Logjam? 09.12.2020 2:24
Congress is making progress on a COVID fiscal relief package, but previous efforts to strike a deal haven’t borne fruit. Why this time may be different.
Mike Wilson: Closing the Books on 2020 07.12.2020 3:29
Despite a year of high uncertainty, 2020 may end as a strong year for nearly every asset class—which means it may be time to step back and take a breath.
Andrew Sheets: Corporate Credit’s Surprising Resiliency 04.12.2020 3:27
Corporate credit defaults have been relatively low considering the outsized shock of COVID-19. Do muted default rates also mean a muted recovery?
Michael Zezas: What Happens Next on U.S.-China Trade? 02.12.2020 3:05
Will a Biden administration mean a reduction of trade barriers between the U.S. and China. The answer for investors: like most questions on trade, it’s a bit nuanced.
China 2021: The Consumer Roars Back 01.12.2020 11:32
China’s consumers could emerge as a key GDP growth driver in 2021, fueled by COVID-19 vaccine availability, a recovery in the job market and pent-up savings by households.
Mike Wilson: A November to Remember 30.11.2020 2:55
Markets have spent November celebrating upbeat vaccine news and closure on U.S. election uncertainty. After a strong month, are equities headed for another reset?
Andrew Sheets: Are Emerging Markets Reemerging? 27.11.2020 3:31
Emerging market assets are poised to redeem some of their historic underperformance in 2021, but not all assets and indices in the class are equally positioned to take advantage of the cyclical upturn. Chief Cross-Asset Strategist Andrew Sheets explains.
Michael Zezas: The Real Risk of Fed/Treasury Conflict 25.11.2020 2:13
A rare open disagreement between the Fed and the Treasury may have policy implications in the longer term. Michael Zezas, Head of U.S. Public Policy Research, explains.
U.S. Outlook 2021: Momentum Toward Recovery 24.11.2020 14:20
Although the U.S. faces a challenging winter, vaccine availability and momentum could propel the economy to expand an impressive 6% in 2021. The forecast for investors.
Mike Wilson: Giving Thanks for a Brighter 2021 23.11.2020 3:09
As Thanksgiving approaches in the U.S., it’s worth taking a moment to be thankful for potential vaccines, a remarkably resilient economy and the strength of the human spirit.
Special Episode: 2021 Global Outlook 21.11.2020 15:15
Global economies are set for next phase of a V-shaped recovery in both developed and emerging markets. Why that could be good news for equities and credit markets.
Michael Zezas: Will D.C. Rein In Big Tech? 18.11.2020 2:17
Washington D.C. has become increasingly interested in tech regulation, but what’s the likelihood in the next two years? And what could it mean for tech stocks?
Mike Wilson: 2021 Preview - A Bull with Room to Run 16.11.2020 3:36
Although near-term worries about the coronavirus and higher interest rates could challenge company valuations, the 12-month U.S. equities outlook may be just what the doctor ordered.
Andrew Sheets: An Artificial Calm? 13.11.2020 2:59
Confidence in the ability of central bank to suppress market volatility through aggressive policy may be misplaced.
Matt Hornbach: 2021 - Another Big Year for Liquidity? 12.11.2020 3:54
G10 central banks could inject another $2.8 trillion of liquidity next year—over twice the amount in any year prior to this one. How will this impact rates and currencies?
Michael Zezas: Vaccine-driven Rebound Could Help Munis 11.11.2020 2:38
Although improving economic growth and rising inflation could present challenges for bond investors, “re-opening” could bring benefit for municipal bonds.
Reza Moghadam: Amid Lockdowns, Europe Looks to a Vaccine 10.11.2020 4:42
Although COVID-19 new case rates have been climbing in Europe, the impact of this second wave may not be as severe this time around.
Mike Wilson: Markets Cheer Clarity on Vaccine, Election 09.11.2020 3:35
Upbeat news on a coronavirus vaccine and a win for President-elect Biden drive stocks significantly higher. How should investors trade a potentially earlier re-opening?
Special Episode: Markets Parse Election Results, Jobs Report 06.11.2020 8:49
All eyes are on the U.S. Presidential race as markets also weigh climbing coronavirus cases in the U.S., fiscal stimulus uncertainty and October’s jobs report.
Michael Zezas: Breaking - Why Post-Election Day Just Got Trickier 05.11.2020 2:48
Amidst the uncertainty, three topics should be front of mind for investors: implications of a divided government, the path to fiscal stimulus and tax changes.
Mike Wilson: Is the Worst of the Correction Over? 02.11.2020 3:23
Although some volatility may lie ahead, the end of the U.S. election cycle and progress on a potential coronavirus vaccine may bring some optimism to markets.
Andrew Sheets: A Transformational Sweep? 30.10.2020 2:48
A look at the 2008 and 2016 U.S. elections suggests that a sweep by either Democrats or Republicans could push stocks and bond yields higher in 2021.
Michael Zezas: Election Night Strategy for Investors 28.10.2020 2:49
For investors, election night could hinge on moments when markets conclude who has won, not necessarily on when media networks call a winner.
Mike Wilson: 3 Sticking Points for U.S. Equities 26.10.2020 3:44
U.S. equity markets have been stuck range bound due to three key concerns, but investors could use that uncertainty to their advantage.
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.